These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 32980676

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.
    Dieltjens T, Heyndrickx L, Willems B, Gray E, Van Nieuwenhove L, Grupping K, Vanham G, Janssens W.
    Retrovirology; 2009 Dec 14; 6():113. PubMed ID: 20003438
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
    Jacob RA, Moyo T, Schomaker M, Abrahams F, Grau Pujol B, Dorfman JR.
    J Virol; 2015 May 14; 89(10):5264-75. PubMed ID: 25673728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R, Huarte N, Julien JP, Kunert R, Pai EF, Nieva JL.
    AIDS Res Hum Retroviruses; 2011 Aug 14; 27(8):863-76. PubMed ID: 21142698
    [Abstract] [Full Text] [Related]

  • 7. Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors.
    Zhang X, Han X, Dai D, Bao M, Zhang Z, Zhang M, Bice T, Zhao M, Cao Y, Shang H.
    Braz J Infect Dis; 2012 Aug 14; 16(6):510-6. PubMed ID: 23141970
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
    Ye L, Wen Z, Dong K, Wang X, Bu Z, Zhang H, Compans RW, Yang C.
    PLoS One; 2011 Aug 14; 6(5):e14813. PubMed ID: 21625584
    [Abstract] [Full Text] [Related]

  • 10. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.
    Wahome N, Pfeiffer T, Ambiel I, Yang Y, Keppler OT, Bosch V, Burkhard P.
    Chem Biol Drug Des; 2012 Sep 14; 80(3):349-57. PubMed ID: 22650354
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.
    Zhai Y, Zhong Z, Zariffard M, Spear GT, Qiao L.
    Vaccine; 2013 Nov 04; 31(46):5422-9. PubMed ID: 24055348
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
    Ringel O, Müller K, Koch J, Brill B, Wolf T, Stephan C, Vieillard V, Debré P, Dietrich U.
    AIDS Res Hum Retroviruses; 2018 Apr 04; 34(4):365-374. PubMed ID: 29262692
    [Abstract] [Full Text] [Related]

  • 18. Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.
    Venditto VJ, Wieczorek L, Molnar S, Teque F, Landucci G, Watson DS, Forthal D, Polonis VR, Levy JA, Szoka FC.
    Clin Vaccine Immunol; 2014 Aug 04; 21(8):1086-93. PubMed ID: 24872518
    [Abstract] [Full Text] [Related]

  • 19. Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.
    Yi G, Lapelosa M, Bradley R, Mariano TM, Dietz DE, Hughes S, Wrin T, Petropoulos C, Gallicchio E, Levy RM, Arnold E, Arnold GF.
    PLoS One; 2013 Aug 04; 8(9):e72205. PubMed ID: 24039745
    [Abstract] [Full Text] [Related]

  • 20. Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.
    Dennison SM, Stewart SM, Stempel KC, Liao HX, Haynes BF, Alam SM.
    J Virol; 2009 Oct 04; 83(19):10211-23. PubMed ID: 19640992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.